SCHEMBL23937743

SCHEMBL23937743

CNS(=O)(=O)c1nc(O)c2ccn(C)c2n1

nearest known ligand 0.37

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 1/20 0.34
LMNA P02545 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
NOTUM Q6P988 1/20 0.30
HRH4 Q9H3N8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23937754 0.82 HRH4 (0.34) NOTUMHRH4
SCHEMBL20674079 0.77 PDE2A (0.40) FTOSMN1; SMN2
SCHEMBL21440750 0.75
SCHEMBL23937755 0.75 FTO (0.36) FTOLMNA
SCHEMBL23937757 0.72 PKM (0.35) FTOLMNA
SCHEMBL23937851 0.72 TLR7 (0.35) HTTSMN1; SMN2NOTUMHRH4
SCHEMBL18711826 0.71 HRH4 (0.36) NOTUMHRH4
SCHEMBL31514720 0.69 GAA (0.36) NOTUMHRH4
SCHEMBL28904493 0.69 GAA (0.36) NOTUMHRH4
SCHEMBL19341247 0.69 HRH4 (0.51) NOTUMHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed